Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,303.60Prev. Close
1,288.70Volume
19,91,213Total traded value
255 CrUpper Circuit
1,407.30Lower Circuit
1,151.50Fundamentals
| Market Cap | ₹1,07,628Cr |
| ROE | 16.86% |
| P/E Ratio(TTM) | 18.74 |
| EPS(TTM) | 68.81 |
| P/B Ratio | 3.21 |
| Dividend Yield | 0.62% |
| Industry P/E | 35.31 |
| Book Value | 401.98 |
| Debt to Equity | 0.14 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Dr.reddy's Laboratories Ltd
Dr. Reddy's is a global pharmaceutical company focused on affordable and innovative medicines in key areas including gastrointestinal, cardiovascular, and oncology. Guided by its purpose of 'Good Health Can't Wait', the company is committed to accelerating access to essential treatments for healthier lives. This year, the company's medicines have reached approximately 756 million patients across the globe through its wide-reaching operations.;
| Parent Organisation | Dr.reddy's Laboratories Ltd |
| Managing Director | Mr. Gunupati Prasad |
| NSE Symbol | DRREDDY |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.01 | ||
| Cipla | NA (0.00%) | 24.96 | ||
| Mankind Pharma | NA (0.00%) | 52.80 | ||
| Zydus Lifesciences | NA (0.00%) | 21.36 |